Tenor Capital Management »

Travere Therapeutics shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $20M 14M 1.43

More positions owned by Tenor Capital Management

Interdigital Note 3.500% 6/0 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)
Ringcentral Note 3/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Akamai Technologies Note 0.375% 9/0 (Principal)
Bentley Sys Note 0.125% 1/1 (Principal)
Jamf Hldg Corp Note 0.125% 9/0 (Principal)
Unity Software Note 11/1 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Haemonetics Corp Mass Note 3/0 (Principal)
Cloudflare Note 8/1 (Principal)
Tripadvisor Note 0.250% 4/0 (Principal)
Biomarin Pharmaceutical Note 1.250% 5/1 (Principal)
Shake Shack Note 3/0 (Principal)
Confluent Note 1/1 (Principal)

View all positions for Tenor Capital Management

Top funds holding Travere Therapeutics

Linden Advisors
Context Capital Management
D. E. Shaw & Co
FMR
Millennium Management
Advent Capital Management
Tenor Capital Management
Lord, Abbett & Co
Affinity Asset Advisors
Shenkman Capital Management
Goldman Sachs Group
M&G
Point72 Asset Management
BlackRock
Polar Capital Holdings

View all funds holding Travere Therapeutics